Product Information
HALOPERIDOL DEC 50 MG/ML VIAL is a generic product labeled by BluePoint Laboratories, priced at $12.0521 per ML under NDC 68001065751. Its NADAC has been published 49 times since Oct 29, 2025.
FDA first approved this application on Oct 22, 2019. Its Orange Book therapeutic-equivalence code is AO.
Strength
50 mg/mL
Manufacturer
BluePoint LaboratoriesNDC
68001065751
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOL DECANOATEApproval Type
Generic (ANDA)
FDA Application
ANDA211180FDA Approved
10/22/2019
TE Code
AO
On Market Since
6/12/2025
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has been published 49 times since Oct 29, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0521 per ML |
|---|---|
| All-time high | $15.9015 (Nov 12, 2025) |
| All-time low | $11.8293 (Oct 29, 2025) |
| 52-week high | $15.9015 |
| 52-week low | $11.8293 |
| Median price | $12.5290 |
| Average price | $13.2806 |
| Largest weekly change | +34.4% (Nov 5, 2025) |
| Weeks tracked | 49 |
| Tracking since | Oct 29, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol decanoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL DEC 50 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL DEC 50 MG/ML VIAL, manufactured by BluePoint Laboratories, is $12.0521 per ML (NDC 68001065751), effective Sep 30, 2026.
How has the price of HALOPERIDOL DEC 50 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 49 weekly CMS publications since Oct 29, 2025.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL DEC 50 MG/ML VIAL?
Since Oct 29, 2025, the NADAC for HALOPERIDOL DEC 50 MG/ML VIAL has ranged from a low of $11.8293 (Oct 29, 2025) to a high of $15.9015 (Nov 12, 2025), with a median of $12.5290 per ML.
Are there cheaper alternatives to HALOPERIDOL DEC 50 MG/ML VIAL?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HALOPERIDOL DEC 50 MG/ML VIAL, is $6.5723 per ML — about 45% below HALOPERIDOL DEC 50 MG/ML VIAL.
Who manufactures HALOPERIDOL DEC 50 MG/ML VIAL?
HALOPERIDOL DEC 50 MG/ML VIAL (NDC 68001065751) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.